Intrapartum exposure to synthetic oxytocin, maternal BMI, and neurodevelopmental outcomes in children within the ECHO consortium

Lisa Kurth,T. Michael O’Shea,Irina Burd,Anne L. Dunlop,Lisa Croen,Greta Wilkening,Ting-ju Hsu,Stephan Ehrhardt,Arvind Palanisamy,Monica McGrath,Marie L. Churchill,Daniel Weinberger,Marco Grados,Dana Dabelea
DOI: https://doi.org/10.1186/s11689-024-09540-1
2024-05-28
Journal of Neurodevelopmental Disorders
Abstract:Synthetic oxytocin (sOT) is frequently administered during parturition. Studies have raised concerns that fetal exposure to sOT may be associated with altered brain development and risk of neurodevelopmental disorders. In a large and diverse sample of children with data about intrapartum sOT exposure and subsequent diagnoses of two prevalent neurodevelopmental disorders, i.e., attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), we tested the following hypotheses: (1) Intrapartum sOT exposure is associated with increased odds of child ADHD or ASD; (2) associations differ across sex; (3) associations between intrapartum sOT exposure and ADHD or ASD are accentuated in offspring of mothers with pre-pregnancy obesity.
neurosciences,clinical neurology
What problem does this paper attempt to address?